Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer

Katsuyuki Hotta, Yoshihiko Segawa, Nagio Takigawa, Daizo Kishino, Hideyuki Saeki, Masao Nakata, Koichi Mandai, Kenji Eguchi

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The relationship between preoperative serum carcinoembryonic antigen (CEA) level and treatment outcome for 39 clinical-stage I patients with surgically resected non-small-cell lung cancer (NSCLC) was retrospectively studied. Serum CEA levels were measured with an enzyme-linked immunosorbent assay kit, with the upper limit of normal defined as 6.7 ng/mL based on the 95% specificity level for benign lung disease in our hospital. Patients with serum CEA ≥ 6.7 ng/mL (n = 9) were more likely to have advanced disease at surgery than those with serum CEA <6.7 ng/mL (n = 30) (77.8% vs 16.7%, p = 0.0049). This increase in disease stage at surgery was mainly due to mediastinal lymph node metastasis. The sensitivity and specificity of serum CEA in the detection of pathological N2 disease were 62.5% and 87.1%, respectively. Survival for the high CEA group was significantly worse than that for the low CEA group (median survival time, 40.2 vs 75.8 months, p = 0.0125). Relapse-free survival for the high CEA group was also poorer than that of the low CEA group (p = 0.0032). In a multivariate analysis, serum CEA level was the most dominant factor affecting relapse-free survival (hazard ratio 6.68, p = 0.0053). These findings suggest that preoperative serum CEA level is useful not only in detection of mediastinal lymph node metastasis, but also in prediction of survival for clinical-stage I patients with NSCLC.

Original languageEnglish
Pages (from-to)2177-2180
Number of pages4
JournalAnticancer Research
Volume20
Issue number3 B
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Carcinoembryonic Antigen
Non-Small Cell Lung Carcinoma
Serum
Survival
Lymph Nodes
Neoplasm Metastasis
Recurrence
Lung Diseases
Multivariate Analysis
Enzyme-Linked Immunosorbent Assay
Sensitivity and Specificity

Keywords

  • Carcinoembryonic antigen
  • Non-small-cell lung cancer
  • Surgical resection

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer. / Hotta, Katsuyuki; Segawa, Yoshihiko; Takigawa, Nagio; Kishino, Daizo; Saeki, Hideyuki; Nakata, Masao; Mandai, Koichi; Eguchi, Kenji.

In: Anticancer Research, Vol. 20, No. 3 B, 2000, p. 2177-2180.

Research output: Contribution to journalArticle

Hotta, Katsuyuki ; Segawa, Yoshihiko ; Takigawa, Nagio ; Kishino, Daizo ; Saeki, Hideyuki ; Nakata, Masao ; Mandai, Koichi ; Eguchi, Kenji. / Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer. In: Anticancer Research. 2000 ; Vol. 20, No. 3 B. pp. 2177-2180.
@article{49f568d531b84c789fd8564fd8b91882,
title = "Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer",
abstract = "The relationship between preoperative serum carcinoembryonic antigen (CEA) level and treatment outcome for 39 clinical-stage I patients with surgically resected non-small-cell lung cancer (NSCLC) was retrospectively studied. Serum CEA levels were measured with an enzyme-linked immunosorbent assay kit, with the upper limit of normal defined as 6.7 ng/mL based on the 95{\%} specificity level for benign lung disease in our hospital. Patients with serum CEA ≥ 6.7 ng/mL (n = 9) were more likely to have advanced disease at surgery than those with serum CEA <6.7 ng/mL (n = 30) (77.8{\%} vs 16.7{\%}, p = 0.0049). This increase in disease stage at surgery was mainly due to mediastinal lymph node metastasis. The sensitivity and specificity of serum CEA in the detection of pathological N2 disease were 62.5{\%} and 87.1{\%}, respectively. Survival for the high CEA group was significantly worse than that for the low CEA group (median survival time, 40.2 vs 75.8 months, p = 0.0125). Relapse-free survival for the high CEA group was also poorer than that of the low CEA group (p = 0.0032). In a multivariate analysis, serum CEA level was the most dominant factor affecting relapse-free survival (hazard ratio 6.68, p = 0.0053). These findings suggest that preoperative serum CEA level is useful not only in detection of mediastinal lymph node metastasis, but also in prediction of survival for clinical-stage I patients with NSCLC.",
keywords = "Carcinoembryonic antigen, Non-small-cell lung cancer, Surgical resection",
author = "Katsuyuki Hotta and Yoshihiko Segawa and Nagio Takigawa and Daizo Kishino and Hideyuki Saeki and Masao Nakata and Koichi Mandai and Kenji Eguchi",
year = "2000",
language = "English",
volume = "20",
pages = "2177--2180",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3 B",

}

TY - JOUR

T1 - Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer

AU - Hotta, Katsuyuki

AU - Segawa, Yoshihiko

AU - Takigawa, Nagio

AU - Kishino, Daizo

AU - Saeki, Hideyuki

AU - Nakata, Masao

AU - Mandai, Koichi

AU - Eguchi, Kenji

PY - 2000

Y1 - 2000

N2 - The relationship between preoperative serum carcinoembryonic antigen (CEA) level and treatment outcome for 39 clinical-stage I patients with surgically resected non-small-cell lung cancer (NSCLC) was retrospectively studied. Serum CEA levels were measured with an enzyme-linked immunosorbent assay kit, with the upper limit of normal defined as 6.7 ng/mL based on the 95% specificity level for benign lung disease in our hospital. Patients with serum CEA ≥ 6.7 ng/mL (n = 9) were more likely to have advanced disease at surgery than those with serum CEA <6.7 ng/mL (n = 30) (77.8% vs 16.7%, p = 0.0049). This increase in disease stage at surgery was mainly due to mediastinal lymph node metastasis. The sensitivity and specificity of serum CEA in the detection of pathological N2 disease were 62.5% and 87.1%, respectively. Survival for the high CEA group was significantly worse than that for the low CEA group (median survival time, 40.2 vs 75.8 months, p = 0.0125). Relapse-free survival for the high CEA group was also poorer than that of the low CEA group (p = 0.0032). In a multivariate analysis, serum CEA level was the most dominant factor affecting relapse-free survival (hazard ratio 6.68, p = 0.0053). These findings suggest that preoperative serum CEA level is useful not only in detection of mediastinal lymph node metastasis, but also in prediction of survival for clinical-stage I patients with NSCLC.

AB - The relationship between preoperative serum carcinoembryonic antigen (CEA) level and treatment outcome for 39 clinical-stage I patients with surgically resected non-small-cell lung cancer (NSCLC) was retrospectively studied. Serum CEA levels were measured with an enzyme-linked immunosorbent assay kit, with the upper limit of normal defined as 6.7 ng/mL based on the 95% specificity level for benign lung disease in our hospital. Patients with serum CEA ≥ 6.7 ng/mL (n = 9) were more likely to have advanced disease at surgery than those with serum CEA <6.7 ng/mL (n = 30) (77.8% vs 16.7%, p = 0.0049). This increase in disease stage at surgery was mainly due to mediastinal lymph node metastasis. The sensitivity and specificity of serum CEA in the detection of pathological N2 disease were 62.5% and 87.1%, respectively. Survival for the high CEA group was significantly worse than that for the low CEA group (median survival time, 40.2 vs 75.8 months, p = 0.0125). Relapse-free survival for the high CEA group was also poorer than that of the low CEA group (p = 0.0032). In a multivariate analysis, serum CEA level was the most dominant factor affecting relapse-free survival (hazard ratio 6.68, p = 0.0053). These findings suggest that preoperative serum CEA level is useful not only in detection of mediastinal lymph node metastasis, but also in prediction of survival for clinical-stage I patients with NSCLC.

KW - Carcinoembryonic antigen

KW - Non-small-cell lung cancer

KW - Surgical resection

UR - http://www.scopus.com/inward/record.url?scp=0033877729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033877729&partnerID=8YFLogxK

M3 - Article

C2 - 10928173

AN - SCOPUS:0033877729

VL - 20

SP - 2177

EP - 2180

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3 B

ER -